- Home
- WALD vs CMPX Comparison
WALD vs CMPX Comparison
Compare WALD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- CMPX
- Stock Information
- Founded
- WALD 1988
- CMPX 2014
- Country
- WALD United States
- CMPX United States
- Employees
- WALD N/A
- CMPX N/A
- Industry
- WALD Package Goods/Cosmetics
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- CMPX Health Care
- Exchange
- WALD Nasdaq
- CMPX Nasdaq
- Market Cap
- WALD 306.3M
- CMPX 291.8M
- IPO Year
- WALD 2021
- CMPX N/A
- Fundamental
- Price
- WALD $1.83
- CMPX $3.56
- Analyst Decision
- WALD Strong Buy
- CMPX Strong Buy
- Analyst Count
- WALD 5
- CMPX 8
- Target Price
- WALD $4.96
- CMPX $13.50
- AVG Volume (30 Days)
- WALD 527.9K
- CMPX 989.7K
- Earning Date
- WALD 11-11-2025
- CMPX 11-11-2025
- Dividend Yield
- WALD N/A
- CMPX N/A
- EPS Growth
- WALD N/A
- CMPX N/A
- EPS
- WALD N/A
- CMPX N/A
- Revenue
- WALD $273,868,000.00
- CMPX N/A
- Revenue This Year
- WALD $10.37
- CMPX N/A
- Revenue Next Year
- WALD $14.37
- CMPX N/A
- P/E Ratio
- WALD N/A
- CMPX N/A
- Revenue Growth
- WALD 25.55
- CMPX N/A
- 52 Week Low
- WALD $1.48
- CMPX $1.27
- 52 Week High
- WALD $4.40
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- WALD 52.51
- CMPX 66.26
- Support Level
- WALD $1.66
- CMPX $3.37
- Resistance Level
- WALD $1.79
- CMPX $3.70
- Average True Range (ATR)
- WALD 0.13
- CMPX 0.18
- MACD
- WALD 0.04
- CMPX 0.02
- Stochastic Oscillator
- WALD 81.40
- CMPX 79.05
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.